Upfront tumour genotyping is now considered an essential step in guiding treatment
decision-making in the management of patients with advanced-stage non-small-cell lung …

Circulating Tumor Cells (CTCs) are cancer cells that split away from the primary tumor and
appear in the circulatory system as singular units or clusters, which was first reported by Dr …

Liquid biopsy is an emerging technology with a potential role in the screening and early
detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and …

Circulating tumor cells (CTCs), detached from the primary tumor or metastases and shed in
the patient's bloodstream, represent a relatively easily obtainable sample of the cancer …

Non-small cell lung cancer (NSCLC) is one of the most threatening malignancies to human
health and life. In most cases, patients with NSCLC are already at an advanced stage when …

(1) Background: Circulating tumor cell (CTC) clusters are emerging as clinically significant
harbingers of metastases in solid organ cancers. Prior to engaging these CTC clusters in …

Lung cancer accounts for most cancer-related deaths worldwide and has an overall 5-year
survival rate of~ 15%. Cell lines have played important roles in the study of cancer biology …

Lung cancer is the leading cause of cancer morbidity and mortality worldwide and early
diagnosis is crucial for the management and treatment of this disease. Non-invasive means …

The prognosis of lung cancer patients with different clinical stages is significantly different.
The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be …

Simple Summary Liquid biopsy has recently been introduced as a novel method in cancer
diagnostics. It is less invasive for patients than conventional tissue biopsies, as the assay …